[New biomarkers for prostate cancer].
Prostate cancer is one of the most common cancers in Western men. In Japan, the incidence of this malignancy is increasing. Recent advances in molecular biology brought new biomarkers to prostate cancer diagnosis. In this article, we describe new biomarkers including serum and genetic and histochemical markers for screening, staging and drug selection for the management of prostate cancer patients.
Suzuki
Hiroyoshi
H
Department of Urology, Graduate School of Medicine, Chiba University.
Shimbo
Masaki
M
Ichikawa
Tomohiko
T
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000235:genetics; D000912:Antibodies, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D006801:Humans; D007519:Isoantigens / Q000097:blood; D019656:Loss of Heterozygosity; D008297:Male; D025202:Molecular Diagnostic Techniques; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics; D011110:Polymorphism, Genetic; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000235:genetics; D040901:Proteomics; D011944:Receptors, Androgen / Q000235:genetics; D011971:Receptors, Immunologic / Q000235:genetics; D051116:Receptors, Scavenger; D016159:Tumor Suppressor Protein p53 / Q000276:immunology
D000912:Antibodies, Neoplasm; D014408:Biomarkers, Tumor; C421605:ELAC2 protein, human; D007519:Isoantigens; D009363:Neoplasm Proteins; D011944:Receptors, Androgen; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger; D016159:Tumor Suppressor Protein p53; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase; D017430:Prostate-Specific Antigen